GDLSK

Covid

USTR EXTENDS CERTAIN CHINA 301 EXCLUSIONS COVERING CERTAIN MEDICAL-CARE PRODUCTS THROUGH SEPTEMBER 30, 2021

In a notice recently posted on its website, the Office of the U.S. Trade Representative (“USTR”) has announced that it is extending 99 expiring China 301 tariff exclusions on medical-care and/or COVID response products.  The exclusions on the products in question had been previously extended through March 31, 2021.  The USTR has decided to further […]

UPDATE: USTR ANNOUNCES ADDITIONAL EXCLUSIONS GRANTED ON SEC. 301 LIST 3 PRODUCTS

On May 4, 2020, the U.S. Trade Representative (“USTR”) announced that 146 items will be excluded from the Section 301 trade remedies imposed on Chinese-origin products.  The newly announced exclusions all relate to items on China 301 List 3 (which is part of the $200 billion trade action) which, unless excluded, are currently subject to […]